Skip to Main Content

Author Details

Lisa E Gralinski
University of North Carolina at Chapel Hill
2002
77
46
PMIDPaper TitleJournal TitlePublished Year
35194605A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.bioRxiv2022
35654851Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.Nat Immunol2022
35931818Understanding COVID-19-associated coagulopathy.Nat Rev Immunol2022
35677067A Multitrait Locus Regulates Sarbecovirus Pathogenesis.bioRxiv2022
35862771A Multitrait Locus Regulates Sarbecovirus Pathogenesis.mBio2022
35357886A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.Sci Immunol2022
35857635SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.Sci Transl Med2022
35291291Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease.bioRxiv2022
35194605A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.bioRxiv2022
35677067A Multitrait Locus Regulates Sarbecovirus Pathogenesis.bioRxiv2022
35857635SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.Sci Transl Med2022
35862771A Multitrait Locus Regulates Sarbecovirus Pathogenesis.mBio2022
35357886A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.Sci Immunol2022
35654851Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.Nat Immunol2022
35931818Understanding COVID-19-associated coagulopathy.Nat Rev Immunol2022
35291291Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease.bioRxiv2022
33469219Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.Nature2021
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
34117252SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.Nat Commun2021
33469219Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.Nature2021
34159335Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.bioRxiv2021
33513210Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.PLoS Pathog2021
33561864SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.Nature2021
34334300Coagulation and wound repair during COVID-19.J Heart Lung Transplant2021
33495307Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.Science2021
34523968Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.J Virol2021
34372702Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury.mBio2021
33495307Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.Science2021
33513210Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.PLoS Pathog2021
33561864SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.Nature2021
34523968Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.J Virol2021
34159335Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.bioRxiv2021
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
34117252SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.Nat Commun2021
34372702Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury.mBio2021
34334300Coagulation and wound repair during COVID-19.J Heart Lung Transplant2021
31621854Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.J Infect Dis2020
31801868Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.J Virol2020
32348764Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross.Cell Rep2020
31621854Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.J Infect Dis2020
31991541Return of the Coronavirus: 2019-nCoV.Viruses2020
32931734A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.Cell2020
32526206SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.Cell2020
33139569Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.Proc Natl Acad Sci U S A2020
33031744A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.Cell2020
33236009An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19.bioRxiv2020
33184236SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.Science2020
33024969SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo.bioRxiv2020
32854108A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.Nature2020
32511409Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals.bioRxiv2020
  • 1 - 50 of 154

Recommended Authors

Yale University
Career Start Year 2018
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2018
Number of shared co-authors 1
Yale University School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 9
Gladstone Institute of Virology
Career Start Year 2015
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 2
University of Geneva
Career Start Year 2014
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 0
University College London
Career Start Year 2013
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR 9
Career Start Year 2012
Number of shared co-authors 0
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 4
Yale University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 1
University of Washington
Career Start Year 2009
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 2
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 2
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 5
University of California san francisco
Career Start Year 2006
Number of shared co-authors 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 10
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 6
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 9
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1997
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 8
University College London
Career Start Year 1992
Number of shared co-authors 1
Yale University
Career Start Year 1990
Number of shared co-authors 5

Collaborators

University of North Carolina
Co-authored papers 66
University of Texas Medical Branch
Co-authored papers 30
University of North Carolina at Chapel Hill
Co-authored papers 29
University of North Carolina at Chapel Hill
Co-authored papers 25
University of North Carolina.
Co-authored papers 23
University of North Carolina at Chapel Hill.
Co-authored papers 19
University of North Carolina at Chapel Hill
Co-authored papers 17
University of North Carolina
Co-authored papers 16
University of North Carolina
Co-authored papers 15
University of Washington
Co-authored papers 15
Oregon Health & Science University, University of California Berkeley
Co-authored papers 12
Pacific Northwest National Laboratory
Co-authored papers 12
The University of North Carolina at Chapel Hill
Co-authored papers 11
National Center for Toxicological Research
Co-authored papers 11
The University of North Carolina at Chapel Hill
Co-authored papers 9
Influenza Research Institute, University of Wisconsin
Co-authored papers 9
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Co-authored papers 9
Co-authored papers 9
University of North Carolina at Chapel Hill
Co-authored papers 9
University of North Carolina at Chapel Hill
Co-authored papers 8
Co-authored papers 8
Pacific Northwest National Laboratory (PNNL)
Co-authored papers 8
Pacific Northwest National Laboratory
Co-authored papers 7
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 7
Co-authored papers 7
Pacific Northwest National Laboratory
Co-authored papers 7
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 7
University of North Carolina
Co-authored papers 7
Pacific Northwest National Laboratory
Co-authored papers 6
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 6